86Y-DOTA(0)- d-Phe(1)-Tyr(3)-octreotide (SMT487) - a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion - Jamar, F; Barone, R; Mathieu, I (Eur J Nucl Med Mol Imaging, 2003)
et al.